Clay B Siegall Shattuck Labs, Inc. (STTK) insider trading activity

STTK Quotes by TradingView

Clay B Siegall is of Shattuck Labs, Inc.. Currently has a direct ownership of 128,054 shares of STTK, which is worth approximately $97,321. The most recent transaction as insider was on Aug 25, 2025, when has been sold 128,054 shares (Common Stock) at a price of $0.87 per share, resulting in proceeds of $111,406. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 128K
n/a 3M change
n/a 12M change
Total Value Held $97,321

CLAY B SIEGALL Transaction History

Date Transaction Value Shares Traded Shares Held Form
Aug 25 2025
BUY
Grant, award, or other acquisition
$111,406 $0.87 p/Share
128,054 Added 50.0%
128,054 Common Stock

Also insider at

SGEN
Seagen Inc. Healthcare
President & CEO
NRIX
Nurix Therapeutics, Inc. Healthcare
Director
IMNM
Immunome Inc. Healthcare
President and CEO
TALS
Talaris Therapeutics, Inc. Healthcare
Director
CBS

Clay B Siegall

Bothell, WA

Track Institutional and Insider Activities on STTK

Follow Shattuck Labs, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells STTK shares.

Notify only if

Insider Trading

Get notified when an Shattuck Labs, Inc. insider buys or sells STTK shares.

Notify only if

News

Receive news related to Shattuck Labs, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on STTK